Vivimed Labs Limited (NSE|VIVIMEDLAB, BSE532660) is an India-based global supplier of specialty chemicals and pharmaceuticals. Headquartered in Hyderabad, India, Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.
Vivimed Labs operates in 50 countries and SBUs based in America (Vivimed Labs USA Inc) and Europe (Vivimed Labs Europe) along with a marketing office in China.
The major areas of concentration are cosmetics, pharmaceuticals, Nutraceuticals, Photochromics, Natural Actives, colors and dyes. Since 2005, Vivimed has acquired James Robinson, UK and Har-Met International Inc.. The company currently has five manufacturing plants located in India along with R&D labs in the UK and India.
The company's current slogan is "The Beauty of Chemistry".
Vivimed Labs operates in 50 countries and SBUs based in America (Vivimed Labs USA Inc) and Europe (Vivimed Labs Europe) along with a marketing office in China.
The major areas of concentration are cosmetics, pharmaceuticals, Nutraceuticals, Photochromics, Natural Actives, colors and dyes. Since 2005, Vivimed has acquired James Robinson, UK and Har-Met International Inc.. The company currently has five manufacturing plants located in India along with R&D labs in the UK and India.
The company's current slogan is "The Beauty of Chemistry".
Location: India, Telangana, Hyderabad
Employees: 501-1000
Phone: +91 40 6608 6608
Total raised: $42.5M
Founded date: 1991
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.09.2017 | - | $42.5M | - |
Mentions in press and media 11
| Date | Title | Description |
| 12.03.2018 | Vivimed Labs closes in on $50-m European buy | BSE-listed Vivimed Labs, a specialty chemical company, is close to acquiring a European company in a deal estimated at $50 million (Rs 225 crore). Mr Santosh Varalwar, Managing Director, Vivimed Labs, said, “We have identified the target co... |
| 08.01.2018 | Vivimed Labs gets additional $7.5 mn funding from OrbiMed Asia | Drug firm Vivimed Labs today said it has received additional investment of $7.5 million (over Rs 47 crore) from healthcare investment firm OrbiMed Asia in its subsidiary Vivimed Labs (Mascarene). The company had earlier received $42.5 milli... |
| 02.01.2018 | India: Vivimed Labs bags $7.5m additional investment from OrbiMed Asia | Premium Pharmaceuticals firm Vivimed Labs has received an additional investment of $7.5 million from healthcare investment firm OrbiMed Asia in its subsidiary Vivimed Labs (Mascarene). Continue reading this story with a subscription to Deal... |
| 27.09.2017 | India: OrbiMed Asia invests $42.5m in Vivimed Labs’ API unit | Premium Healthcare-focussed investment firm OrbiMed Asia has signed definitive agreements with NSE-listed Vivimed Labs Limited, a pharmaceuticals and specialty chemicals company, for an investment of $42.5 million into the latter’s subsidia... |
| 26.09.2017 | OrbiMed Invests $42.5mm in ViviMed | - |
| 15.03.2012 | Kitara Capital Buys 5.68% In Supreme Infrastructure | Investment firm Kitara Capital has acquired over 5 per cent stake through market deals in Supreme Infrastructure India Ltd, a mid-sized EPC contract firm. The shares were picked up for Rs 23.78 crore on the National Stock Exchange on Wednes... |
| 28.09.2011 | Vivimed Labs gets Rs 127-cr PE funding | Vivimed Labs Ltd has raised Rs 127 crore through preferential allotment of shares to private equity players, NYLIM Jacob Ballas (JB) India Fund and Kitara Capital. The JB Fund invested Rs 67 crore to subscribe to compulsorily convertible pr... |
| 28.09.2011 | Vivimed Labs Raises Rs 127Cr From NYLIM Jacob Ballas, Kitara Cap | Hyderabad-based Vivimed Labs Ltd has raised Rs 127 crore or $27.6 million from private equity firms NYLIM Jacob Ballas Fund III and Kitara Capital, the manufacturer and exporter of specialty chemicals and pharmaceuticals has said in a state... |
| 28.09.2011 | Vivimed Labs Raises INR 127 Crore from Reputed Private Equity Investors | Vivimed Labs Raises INR 127 Crore from Reputed Private Equity Investors 09-28-2011 07:55 AM CET | Business, Economy, Finances, Banking & Insurance Press release from: Vivimed Lab Ltd Hyderabad, September 27, 2011. Vivimed Labs Limited (... |
| 30.08.2011 | Jacob Ballas, Kitara Capital To Invest Rs 127Cr In Vivimed Labs | Hyderabad-based Vivimed Labs Ltd is raising Rs 127.5 crore from Jacob Ballas Capital and Kitara Capital, with the two private equity firms taking over a 13 per cent stake each in the listed firm. Vivimed Labs, a manufacturer and exporter of... |
Show more